Most tools are stuck in two dimensions.
They’re static references, dose calculators, or surveillance platforms — helpful in narrow lanes, but blind to the full picture. They don’t adapt to the patient. They don’t evolve with the data. They don’t guide the clinician forward.
pRxcision was built in a different dimension entirely.
It’s dynamic. Personalized. Real-time AI — not just a lookup tool or a protocol engine.
At its core is something clinicians have never seen before:
The probability that a patient is on an optimized regimen — calculated before a single dose is given. And recalculated as new data arrives, all the way through discharge and oral step-down.
It doesn’t just help with vancomycin or aminoglycosides. It spans the full spectrum of antibiotics. And it’s not reactive — it’s anticipatory.
There’s nothing else like it in the AI-infectious disease space.
Because we didn’t build it to compete with what exists.
We built it to deliver what’s never existed.